Background The long-term follow-up of asymptomatic intracranial hemorrhage (aICH) in patients with acute ischemic stroke after endovascular treatment (EVT) remains controversial. O b j e c t i v e To ...

Introduction/Purpose The eShunt Implant (CereVasc, Inc., Boston, MA, USA) is a novel endovascular cerebrospinal fluid (CSF) shunt developed for the treatment of communicating hydrocephalus. The ...

Results A total of 80 patients who had 82 MMAE procedures were identified and included in the analysis. 77 patients (81.7%) had stable (i.e. equal or improved GCS) neurologic exam pre- and immediately ...

Background Patients with end-stage renal disease (ESRD) are often excluded from clinical trials of endovascular thrombectomy (EVT). This study investigated the outcome in these patients. Methods From ...

Introduction The safety and feasibility of intravenous cangrelor use for neuroendovascular procedures needs to be investigated. Aim of Study To investigate safety and feasibility of intravenous ...

Results In one year, SuperDyna was performed in 52 patients (out of 1,935, 2.6%). 72% were women with a median age of 60 years. Most common reason for the addition of the SuperDyna was for post flow ...

Introduction Glenzocimab is a monoclonal antibody fragment targeting platelet glycoprotein VI, inhibiting platelet activation and aggregation. ACTIMIS study ([NCT03803007][1]) described the safety ...